- Report
- June 2026
- 137 Pages
United Kingdom
From €478EUR$556USD£399GBP
- Report
- March 2024
- 197 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,028GBP
- Report
- March 2024
- 189 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,028GBP
- Report
- March 2024
- 194 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,028GBP
- Report
- March 2024
- 183 Pages
Global
From €3156EUR$3,545USD£2,726GBP
€3506EUR$3,939USD£3,028GBP
- Report
- May 2025
- 100 Pages
China
From €5296EUR$5,950USD£4,575GBP
- Report
- November 2024
- 100 Pages
Global
From €5296EUR$5,950USD£4,575GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2216EUR$2,490USD£1,914GBP
- Report
- February 2026
- 200 Pages
Australia
From €2662EUR$2,990USD£2,299GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2216EUR$2,490USD£1,914GBP
- Report
- July 2025
- 200 Pages
Japan
From €2216EUR$2,490USD£1,914GBP
- Report
- July 2025
- 200 Pages
Australia
From €2216EUR$2,490USD£1,914GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2216EUR$2,490USD£1,914GBP
- Report
- July 2025
- 200 Pages
Australia
From €2216EUR$2,490USD£1,914GBP
- Report
- June 2025
- 200 Pages
India
From €2216EUR$2,490USD£1,914GBP
- Report
- June 2025
- 200 Pages
United States
From €2216EUR$2,490USD£1,914GBP
- Report
- May 2025
- 200 Pages
Global
From €2216EUR$2,490USD£1,914GBP
- Report
- May 2025
- 200 Pages
Global
From €2216EUR$2,490USD£1,914GBP
- Report
- May 2025
- 200 Pages
Europe
From €2216EUR$2,490USD£1,914GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2216EUR$2,490USD£1,914GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more